BamSEC and AlphaSense Join Forces
Learn More

RAPT Therapeutics Inc. – Material Contracts

Formerly NASDAQ: RAPT

Material Contracts Filter

EX-10.1
from 8-K 14 pages Form of Tender and Support Agreement
12/34/56
EX-10.5
from 10-Q 6 pages RAPT Therapeutics, Inc. Non-Employee Director Compensation Policy July 9, 2025
12/34/56
EX-10.4
from 10-Q 10 pages The Plan Provides a Means by Which Eligible Employees of the Company and Certain Designated Related Corporations May Be Given an Opportunity to Purchase Shares of Common Stock. the Plan Permits the Company to Grant a Series of Purchase Rights to Eligible Employees Under an Employee Stock Purchase Plan. (B) the Company, by Means of the Plan, Seeks to Retain the Services of Such Employees, to Secure and Retain the Services of New Employees and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board Will Administer the Plan Unless and Until the Board Delegates Administration of the Plan to a Committee or Committees, as Provided in Section 2(c). (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical). (II) to Designate From Time to Time Which Related Corporations of the Company Will Be Eligible to Participate in the Plan
12/34/56
EX-10.3
from 10-Q 9 pages RAPT Therapeutics, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.2
from 10-Q 11 pages RAPT Therapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from 10-Q 22 pages Appendix B RAPT Therapeutics, Inc. 2025 Equity Incentive Plan Adopted by the Board of Directors: March 25, 2025 Approved by the Stockholders: May 29, 2025 Effective Date: May 29, 2025
12/34/56
EX-10.3
from 10-Q 11 pages RAPT Therapeutics, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.2
from 10-Q 12 pages RAPT Therapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from 10-Q 19 pages RAPT Therapeutics, Inc. Inducement Plan Adopted by the Board of Directors: March 25, 2025 1. General
12/34/56
EX-10.3
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 87 pages License Agreement by and Between Shanghai Jemincare Pharmaceutical Co., Ltd. and RAPT Therapeutics, Inc. Dated as of December 22, 2024
12/34/56
EX-10.1
from 10-Q 6 pages RAPT Therapeutics, Inc. Non-Employee Director Compensation Policy March 27, 2024
12/34/56
EX-10.21
from 10-K 6 pages RAPT Therapeutics Amendment No. 2 to Clinical Trial Collaboration and Supply Agreement
12/34/56
EX-10.1
from 10-Q 5 pages RAPT Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10
from 10-K 5 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) the Type That the Registrant Treats as Private and Confidential RAPT Therapeutics, Inc. (Formerly Flx) Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement
12/34/56
EX-10.1
from 10-Q 5 pages RAPT Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
12/34/56
EX-10.2
from 8-K 17 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.14
from 10-K 5 pages RAPT Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy September 26, 2019
12/34/56